AISL vs SICAGEN: Stock Comparison

AISL vs SICAGEN INDIAUpdated 21 Sept 26, 11:42 AM ISTNSE & company filings

SICAGEN INDIA is the larger company by market capitalisation. AISL shows a higher ROE, lower leverage and a higher ROCE, while SICAGEN INDIA shows a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AISL leads 5; SICAGEN leads 4 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AISLSICAGEN

Valuation lens

What price are you paying?

Market CapContext only
₹64 Cr
₹208 Cr
P/E RatioSame reading
11.41x
P/B RatioSame reading
0.47x
EPSSICAGEN has the higher reading
₹-0.49
₹1.38
Book ValueContext only
₹71.41
₹125.09
Dividend YieldSICAGEN has the higher reading
0%
3.74%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SICAGEN is the larger company
₹208 Cr vs ₹64 Cr
EPS
SICAGEN has higher earnings per share
₹1.38 vs ₹-0.49
Dividend Yield
SICAGEN has a higher dividend yield
3.74% vs 0%
Qtr Sales Growth
AISL has stronger quarterly sales growth
-5.9% vs -53.51%
Qtr Profit Growth
AISL has stronger quarterly profit growth
34.19% vs -20.92%
ROE
AISL has a higher ROE
4.3% vs 3.65%
ROCE
AISL has a higher ROCE
6.04% vs 4.43%
Net Margin
SICAGEN has a higher net margin
1.86% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricAISLSICAGEN
Live Price₹52.88
Day Change0.21%
Volume6,033
52-Week High₹74.06
52-Week Low₹46.55
Distance from 52W High-28.6%

Valuation

MetricAISLSICAGEN
Market Cap₹64 Cr₹208 Cr
P/E Ratio11.41x
P/B Ratio0.47x
EPS₹-0.49₹1.38
Book Value₹71.41₹125.09
Dividend Yield0%3.74%

Growth

MetricAISLSICAGEN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-5.9%-53.51%
Qtr Profit Growth34.19%-20.92%

Profitability & Leverage

MetricAISLSICAGEN
ROE4.3%3.65%
ROCE6.04%4.43%
Net Margin0%1.86%
Operating Margin2.38%3.9%
Debt to Equity0.21x0.29x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAISLSICAGEN
Promoter Holding74.98%23.92%
FII Holding0%2.47%
DII Holding0%0.58%
Public Holding25.02%35.81%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AISL and SICAGEN INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.